N/A
N=105
Behavioral Activation and Medication Optimization In Older Adults Undergoing Cardiac Procedures
Cardiac Surgery · Older Adults · Depression · Anxiety
Bottom Line
View on ClinicalTrials.gov: NCT05575128 ↗Enrolled (actual)
105
Serious AEs
0.0%
Results posted
Apr 2026
Primary outcome: Primary: PHQ-ADS — 18.39; 18.59; 12.33; 11.67 Points
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Behavioral activation (Behavioral); Medication optimzation (Other); Care as usual (Other)
- Age
- Adult, Older Adult · 60+ yrs
- Sex
- All
- Sponsor
- Washington University School of Medicine
- Primary completion
- Mar 2025
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY PHQ-ADS |
18.39; 18.59; 12.33; 11.67; 9.72; 12.60 | — |
Summary
This Hybrid 1 Study will test the effectiveness of a bundled intervention comprised of behavioral activation and medication optimization in reducing symptoms of depression and anxiety in older adults undergoing cardiac surgery (compared with usual care), while examining implementation outcomes.
Eligibility Criteria
Inclusion criteria
- Adults ≥ 60 years
- Scheduled major cardiac procedure
- PHQ-ADS ≥ 10, indicating clinically significant depression or anxiety symptoms
Exclusion criteria
- Barrier to communication (Unable to read, speak, and understand English)
- Severe cognitive impairment screened by the SBT (Short Blessed Test) >10
- Acutely suicidal
- Previous participation in this study or CPMH feasibility study 202101103.
Data sourced from ClinicalTrials.gov (NCT05575128). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.